XML 14 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Changes in Equity - USD ($)
shares in Millions, $ in Millions
Total
Common Stock [Member]
Additional Paid-In Capital [Member]
Retained Earnings [Member]
Net Unrealized Gains (Losses) on Investments [Member]
Foreign Currency Translation Losses [Member]
Nonredeemable Noncontrolling Interests [Member]
Balance at Dec. 31, 2021 $ 75,045 $ 10 $ 0 $ 77,134 $ 423 $ (5,807) $ 3,285
Balance (in shares) at Dec. 31, 2021   941          
Net earnings attributable to UnitedHealth Group common shareholders 5,027     5,027      
Net earnings attributable to nonredeemable noncontrolling interest             88
Net Earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest 5,115            
Other comprehensive income (loss) (642)       (1,560) 918  
Issuances of common stock, and related tax effects (in shares)   3          
Issuances of common stock, and related tax effects 333 $ 0 333        
Share-based compensation 282   282        
Common share repurchases (in shares)   (5)          
Common share repurchases (2,500) $ 0 (484) (2,016)      
Cash dividends paid on common shares (1,363)     (1,363)      
Redeemable noncontrolling interests fair value and other adjustments (131)   (131)        
Acquisition and other adjustments of nonredeemable noncontrolling interests 91           91
Distribution to nonredeemable noncontrolling interests (102)           (102)
Balance at Mar. 31, 2022 76,128 $ 10 0 78,782 (1,137) (4,889) 3,362
Balance (in shares) at Mar. 31, 2022   939          
Balance at Dec. 31, 2022 $ 81,450 $ 9 0 86,156 (2,778) (5,615) 3,678
Balance (in shares) at Dec. 31, 2022 934 934          
Net earnings attributable to UnitedHealth Group common shareholders $ 5,611     5,611      
Net earnings attributable to nonredeemable noncontrolling interest             113
Net Earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest 5,724            
Other comprehensive income (loss) 844       503 341  
Issuances of common stock, and related tax effects (in shares)   2          
Issuances of common stock, and related tax effects 350 $ 0 350        
Share-based compensation 366   366        
Common share repurchases (in shares)   (4)          
Common share repurchases (2,011) $ 0 (633) (1,378)      
Cash dividends paid on common shares (1,537)     (1,537)      
Redeemable noncontrolling interests fair value and other adjustments (83)   (83)        
Acquisition and other adjustments of nonredeemable noncontrolling interests 819           819
Distribution to nonredeemable noncontrolling interests (101)           (101)
Balance at Mar. 31, 2023 $ 85,821 $ 9 $ 0 $ 88,852 $ (2,275) $ (5,274) $ 4,509
Balance (in shares) at Mar. 31, 2023 932 932